Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis : a case-control study. / Dong, Hai Yang; Tong, Min Si; Wang, Juan; Liu, Yuan; Tao, Guang Yu; Petersen, René Horsleben; Jara-Palomares, Luis; Wang, Yi; Sun, Yan Bing; Chen, Jie.

In: Translational Lung Cancer Research, Vol. 12, No. 7, 2023, p. 1539-1548.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dong, HY, Tong, MS, Wang, J, Liu, Y, Tao, GY, Petersen, RH, Jara-Palomares, L, Wang, Y, Sun, YB & Chen, J 2023, 'Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study', Translational Lung Cancer Research, vol. 12, no. 7, pp. 1539-1548. https://doi.org/10.21037/tlcr-23-346

APA

Dong, H. Y., Tong, M. S., Wang, J., Liu, Y., Tao, G. Y., Petersen, R. H., Jara-Palomares, L., Wang, Y., Sun, Y. B., & Chen, J. (2023). Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study. Translational Lung Cancer Research, 12(7), 1539-1548. https://doi.org/10.21037/tlcr-23-346

Vancouver

Dong HY, Tong MS, Wang J, Liu Y, Tao GY, Petersen RH et al. Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study. Translational Lung Cancer Research. 2023;12(7):1539-1548. https://doi.org/10.21037/tlcr-23-346

Author

Dong, Hai Yang ; Tong, Min Si ; Wang, Juan ; Liu, Yuan ; Tao, Guang Yu ; Petersen, René Horsleben ; Jara-Palomares, Luis ; Wang, Yi ; Sun, Yan Bing ; Chen, Jie. / Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis : a case-control study. In: Translational Lung Cancer Research. 2023 ; Vol. 12, No. 7. pp. 1539-1548.

Bibtex

@article{1ac1a9d036dd491bb315627481557442,
title = "Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study",
abstract = "Background: There is growing evidence that misdiagnosis contributes to the high mortality rate in lung cancer patients complicated with pulmonary embolism (PE). This current study analyzed predictors of PE in lung cancer patients with lower extremity deep venous thrombosis (DVT) with the aim of personalizing the treatment and management of patients with PE. Methods: This retrospective case-control study included lung cancer patients with DVT at the emergency department of Shanghai Chest Hospital from January 2018 to December 2019. Patients were classified as having DVT with or without PE. The following characteristics were examined, including age, gender, smoking, hypertension, surgical trauma, hyperlipidemia, long-term bedridden status, calf swelling, coronary heart disease, chronic pulmonary disease, DVT location, DVT type, prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen, and D-dimer, and univariate and multivariate analyses were performed. Results: A total of 90 patients with lung cancer and DVT were analyzed, of whom 60% (54/90) had PE. Those variables independently associated to PE were hypertension [odds ratio (OR): 7.883, 95% confidence interval (CI): 2.038–30.495, P=0.003], long-term bedridden status (OR: 4.166, 95% CI: 1.236–14.044, P=0.021), and D-dimer levels (OR: 2.123, 95% CI: 1.476–3.053, P=0.000) were identified as independent risk factors for PE. The cut-off value of the receiver operating characteristic (ROC) curve for predicting PE by presented scoring system according to the risk factors was 1.5 and the area under the curve (AUC) was 0.84 (P<0.001). Conclusions: Hypertension, being bedridden for an extended period, and elevated serum D-dimer levels were independent risk factors of PE in lung cancer patients with lower extremity DVT. Novel strategies for patient management should be developed to decrease the risk of PE.",
keywords = "computed tomographic pulmonary angiography (CTPA), Lung cancer, pulmonary embolism (PE), venous thrombosis",
author = "Dong, {Hai Yang} and Tong, {Min Si} and Juan Wang and Yuan Liu and Tao, {Guang Yu} and Petersen, {Ren{\'e} Horsleben} and Luis Jara-Palomares and Yi Wang and Sun, {Yan Bing} and Jie Chen",
note = "Funding Information: Funding: This work was supported in part by the Cultivation Fund of Shanghai Chest Hospital (No. 2020YNJCQ12), the Municipality Scientific and Innovative Action Plan of Shanghai (CN) (No. 21142202200), and the Shanghai Key Laboratory Open Project (No. STCSM 22DZ2229005). Publisher Copyright: {\textcopyright} Translational Lung Cancer Research. All rights reserved.",
year = "2023",
doi = "10.21037/tlcr-23-346",
language = "English",
volume = "12",
pages = "1539--1548",
journal = "Translational Lung Cancer Research",
issn = "2226-4477",
publisher = "Society for Translational Medicine (STM)",
number = "7",

}

RIS

TY - JOUR

T1 - Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis

T2 - a case-control study

AU - Dong, Hai Yang

AU - Tong, Min Si

AU - Wang, Juan

AU - Liu, Yuan

AU - Tao, Guang Yu

AU - Petersen, René Horsleben

AU - Jara-Palomares, Luis

AU - Wang, Yi

AU - Sun, Yan Bing

AU - Chen, Jie

N1 - Funding Information: Funding: This work was supported in part by the Cultivation Fund of Shanghai Chest Hospital (No. 2020YNJCQ12), the Municipality Scientific and Innovative Action Plan of Shanghai (CN) (No. 21142202200), and the Shanghai Key Laboratory Open Project (No. STCSM 22DZ2229005). Publisher Copyright: © Translational Lung Cancer Research. All rights reserved.

PY - 2023

Y1 - 2023

N2 - Background: There is growing evidence that misdiagnosis contributes to the high mortality rate in lung cancer patients complicated with pulmonary embolism (PE). This current study analyzed predictors of PE in lung cancer patients with lower extremity deep venous thrombosis (DVT) with the aim of personalizing the treatment and management of patients with PE. Methods: This retrospective case-control study included lung cancer patients with DVT at the emergency department of Shanghai Chest Hospital from January 2018 to December 2019. Patients were classified as having DVT with or without PE. The following characteristics were examined, including age, gender, smoking, hypertension, surgical trauma, hyperlipidemia, long-term bedridden status, calf swelling, coronary heart disease, chronic pulmonary disease, DVT location, DVT type, prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen, and D-dimer, and univariate and multivariate analyses were performed. Results: A total of 90 patients with lung cancer and DVT were analyzed, of whom 60% (54/90) had PE. Those variables independently associated to PE were hypertension [odds ratio (OR): 7.883, 95% confidence interval (CI): 2.038–30.495, P=0.003], long-term bedridden status (OR: 4.166, 95% CI: 1.236–14.044, P=0.021), and D-dimer levels (OR: 2.123, 95% CI: 1.476–3.053, P=0.000) were identified as independent risk factors for PE. The cut-off value of the receiver operating characteristic (ROC) curve for predicting PE by presented scoring system according to the risk factors was 1.5 and the area under the curve (AUC) was 0.84 (P<0.001). Conclusions: Hypertension, being bedridden for an extended period, and elevated serum D-dimer levels were independent risk factors of PE in lung cancer patients with lower extremity DVT. Novel strategies for patient management should be developed to decrease the risk of PE.

AB - Background: There is growing evidence that misdiagnosis contributes to the high mortality rate in lung cancer patients complicated with pulmonary embolism (PE). This current study analyzed predictors of PE in lung cancer patients with lower extremity deep venous thrombosis (DVT) with the aim of personalizing the treatment and management of patients with PE. Methods: This retrospective case-control study included lung cancer patients with DVT at the emergency department of Shanghai Chest Hospital from January 2018 to December 2019. Patients were classified as having DVT with or without PE. The following characteristics were examined, including age, gender, smoking, hypertension, surgical trauma, hyperlipidemia, long-term bedridden status, calf swelling, coronary heart disease, chronic pulmonary disease, DVT location, DVT type, prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen, and D-dimer, and univariate and multivariate analyses were performed. Results: A total of 90 patients with lung cancer and DVT were analyzed, of whom 60% (54/90) had PE. Those variables independently associated to PE were hypertension [odds ratio (OR): 7.883, 95% confidence interval (CI): 2.038–30.495, P=0.003], long-term bedridden status (OR: 4.166, 95% CI: 1.236–14.044, P=0.021), and D-dimer levels (OR: 2.123, 95% CI: 1.476–3.053, P=0.000) were identified as independent risk factors for PE. The cut-off value of the receiver operating characteristic (ROC) curve for predicting PE by presented scoring system according to the risk factors was 1.5 and the area under the curve (AUC) was 0.84 (P<0.001). Conclusions: Hypertension, being bedridden for an extended period, and elevated serum D-dimer levels were independent risk factors of PE in lung cancer patients with lower extremity DVT. Novel strategies for patient management should be developed to decrease the risk of PE.

KW - computed tomographic pulmonary angiography (CTPA)

KW - Lung cancer

KW - pulmonary embolism (PE)

KW - venous thrombosis

U2 - 10.21037/tlcr-23-346

DO - 10.21037/tlcr-23-346

M3 - Journal article

C2 - 37577319

AN - SCOPUS:85170679690

VL - 12

SP - 1539

EP - 1548

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

IS - 7

ER -

ID: 388018841